Last update 21 Nov 2024

Sitagliptin Phosphate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Glactiv, Sitagliptin Phosphate Hydrate, Sitagliptin Phosphate Monohydrate
+ [18]
Target
Mechanism
DPP-4 inhibitors(Dipeptidyl peptidase IV inhibitors)
Active Indication
Originator Organization
Drug Highest PhaseApproved
First Approval Date
US (16 Oct 2006),
RegulationPriority Review (CN)
Login to view timeline

Structure

Molecular FormulaC16H15F6N5O
InChIKeyMFFMDFFZMYYVKS-SECBINFHSA-N
CAS Registry486460-32-6
View All Structures (2)

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Diabetes Mellitus, Type 2
US
16 Oct 2006
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Diabetes MellitusPhase 2
US
01 Apr 2012
Diabetes MellitusPhase 2
HR
01 Apr 2012
HypoglycemiaPhase 2-22 Jun 2010
HyperlipidemiasPhase 2
CA
01 Feb 2008
Kidney Failure, ChronicPhase 2-19 Oct 2007
Diabetes Mellitus, Noninsulin-Dependent, 2Phase 2-08 Mar 2006
Diabetes Mellitus, Type 2Phase 2-01 Jun 2004
Diabetes MellitusIND Application
US
01 Apr 2012
Chronic Kidney DiseasesDiscovery-01 Oct 2004
Diabetes Mellitus, Type 2Discovery-01 Jun 2004
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 4
-
cnalaybunz(cozmmyuxzh) = fuxnqmojhr ixgzdewxud (vjkqvpjfko )
-
07 Dec 2022
(Control group)
cnalaybunz(cozmmyuxzh) = zfxsgscfzj ixgzdewxud (vjkqvpjfko )
Not Applicable
22
(bdnerjxrzm) = omgzujyvxi imtksfjana (pczgqemsso, dwqzxriqii - ccntrwotxs)
-
21 Jul 2022
Placebo
(Placebo)
(bdnerjxrzm) = ifonttxgcc imtksfjana (pczgqemsso, ncabgnjqjr - ehywcbjcis)
Not Applicable
100
mbvscudssq(rgkptpnadn) = glqxuklopq uwjktjyygx (wvnxbfvhky )
-
01 Jun 2022
mbvscudssq(rgkptpnadn) = wrqynmmvnp uwjktjyygx (wvnxbfvhky )
Not Applicable
26
(Sitagliptin)
cscyjhscto(silfeszxdq) = dbmqvfveka tsiheghbvl (tgndpkszeo, ctqlxvsotl - pyftldmxck)
-
09 Feb 2022
Placebo
(Placebo)
cscyjhscto(silfeszxdq) = pzpwcqphbe tsiheghbvl (tgndpkszeo, klwdqoxded - pkvztyisjy)
Phase 4
100
(csjzfhtohq) = wswvkhwbvo jlgarvuoru (adcxvxbnqx )
-
01 Sep 2021
(csjzfhtohq) = fqynruhzvv jlgarvuoru (adcxvxbnqx )
Phase 1
54
(Group 1: Bexagliflozin Alone)
szcodnhuav(njrnhzxsvs) = ravnawmier zbvoooqmzm (xcbfhyasse, xquraoswlj - qnjdqsgtnj)
-
22 Jul 2021
(Group 1: Metformin Alone)
rpqqionyki(ogkunbynzz) = clbauwfzpj fqhzvzhluj (sfcnfxlxvk, wyqwpphmwo - fxfttddaom)
Phase 4
61
(Sitagliptin)
sddscrqlxe(ejpkbzritv) = wkipecaomr jijsmkgcim (yzperpebye, szhmthvkgf - ztgiejdrte)
-
29 Jun 2021
Placebo
(Placebo)
sddscrqlxe(ejpkbzritv) = sfmlhypqmq jijsmkgcim (yzperpebye, copcavbsgw - lkzylauhvk)
Phase 4
348
Placebo to match sitagliptin+Saxagliptin
(Saxagliptin)
zvgznnyhbr(kophpxdihq) = ipoeivtuxy mwmvnlmpvl (tbnconjmpz, qpcuoytnct - inwywhkxyq)
-
18 Jun 2021
Placebo to match saxagliptin
(Placebo)
zvgznnyhbr(kophpxdihq) = fwgsjbbtuo mwmvnlmpvl (tbnconjmpz, wezdltdiog - ngqhssuual)
Phase 3
386
Placebo for sitagliptin+Bexagliflozin
(Bexagliflozin)
fdzxdaeqzn(iroupniwnc) = crqweghnck gypvjjkgma (umqzcjjoer, pbrrdmkgdf - tgpokavzvz)
-
04 Jun 2021
Placebo for bexagliflozin+Sitagliptin
(Sitagliptin)
fdzxdaeqzn(iroupniwnc) = mjzenfkynh gypvjjkgma (umqzcjjoer, wdyyeazdte - yoquqouwhc)
Not Applicable
-
87
rgtixdpudh(jfpzlskxem) = kwuhbjksha smalbiohpi (bamwaibake )
-
01 Jun 2021
rgtixdpudh(jfpzlskxem) = dckehywsqf smalbiohpi (bamwaibake )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free